Navigation Links
Soligenix Announces Publication of Positive Stability Results with RiVax(TM), its Vaccine Against Ricin Toxin
Date:2/2/2010

PRINCETON, N.J., Feb. 2 /PRNewswire-FirstCall/ -- Soligenix, Inc. (OTC Bulletin Board: SNGX) (Soligenix or the Company), a late-stage biotechnology company, announced today the publication of an article in the February 2010 edition of Vaccine, which describes preclinical formulations of RiVax™, its ricin toxin vaccine, with heightened stability. The article was authored by the Company's collaborators at the University of Texas Southwestern Medical Center at Dallas (UT Southwestern) where the vaccine originated. RiVax™ is currently being evaluated in Phase 1 human safety and immunogenicity trials, as well as non-human primate trials for efficacy.

The purpose of this study was to establish preliminary conditions for long-term stability of RiVax™ with the intent of avoiding the cold chain usually required for storage of vaccines. In this publication, a series of formulations of the RiVax™ immunogen, a modified recombinant ricin A chain protein, were examined for comparative effects of storage at room temperature versus refrigeration. The formulations were designed with excipients expected to add to protein stability and then processed by lyophilization to remove water. One combination of lyophilization conditions and excipients was found to result in a vaccine that retained immunogenicity in animals, an index of vaccine potency, for one year at room temperature (the longest time tested). The lead formulation showed no evidence of degradation, whereas unstable control formulations aggregated when reconstituted with water. Moreover, the stabilized vaccine formulation was potent when adsorbed to aluminum hydroxide adjuvant, which is used in many approved vaccines. As shown previously, the aluminum adjuvant enhanced the immunogenicity and potency of RiVax™. The lyophilized vaccin
'/>"/>

SOURCE Soligenix, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Soligenix Announces Publication of Positive Pre-Clinical Results with RiVax(TM), Its Vaccine Against Ricin Toxin
2. Soligenix Announces Initiation of a Phase 1/2 Clinical Trial of SGX201 for the Prevention of Acute Radiation Enteritis
3. Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines
4. ISTA Pharmaceuticals Announces Preliminary, Unaudited Revenue of $110.6 Million in 2009
5. CareFusion Announces 5-Year, Sole Source Pyxis(R) Perioperative Solutions Agreement With CHRISTUS Health
6. BIA Announces Release of Solis(TM) Integrated ESI Management and E-Discovery Platform
7. Pioneer(R) Surgical Technology, Inc. Announces New Expansion Plan
8. Cardica Announces Fiscal 2010 Second Quarter Financial Results
9. Sequenom Announces Addition to Clinical Advisory Board
10. Omnicell Announces Fourth Quarter and Full-Year 2009 Results
11. Life Spine(R) Announces FDA Clearance of DYNA-LINK(R) Spinal System and PRESIDIO(TM) Spinal Plating System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... July 7, 2015   Decision Resources Group ... in dialysis patient management in the U.S. versus ... by U.S. and EU5 nephrologists from approximately 1,870 ... are the most commonly used renal medications in ... differs considerably between the two regions.      ...
(Date:7/7/2015)... FRANCISCO , July 7, 2015 ... reach USD 1,197.7 million by 2020, growing at an estimated ... new study by Grand View Research, Inc. Introduction of innovative ... coupled with growing awareness levels pertaining to the advantages of ... the next six years. In addition, presence of untapped growth ...
(Date:7/7/2015)... , July 7, 2015 EnteroMedics Inc. ... devices that use neuroblocking technology to treat obesity, metabolic ... its previously announced public offering of 32,000,000 units. Each unit ... Series A warrant to purchase one share of common ... Investors whose purchase of units in the offering would ...
Breaking Medicine Technology:Similarities And Differences Exist When Comparing U.S. Versus EU5 Dialysis Patient Management 2Similarities And Differences Exist When Comparing U.S. Versus EU5 Dialysis Patient Management 3Breast Pumps Market To Reach $1,197.7 Million By 2020: Grand View Research, Inc. 2Breast Pumps Market To Reach $1,197.7 Million By 2020: Grand View Research, Inc. 3Breast Pumps Market To Reach $1,197.7 Million By 2020: Grand View Research, Inc. 4EnteroMedics Inc. Announces Pricing of $16.0 Million Public Offering of Common Stock and Warrants 2EnteroMedics Inc. Announces Pricing of $16.0 Million Public Offering of Common Stock and Warrants 3
... CHICAGO and ORANGE, Calif., Feb. 23, 2011 ... (SJHS), a $4.6 billion not-for-profit Catholic healthcare system based in ... in California, West Texas and Eastern New Mexico, has selected ... MDRX ) to streamline patient movement through their ...
... Caliper Life Sciences, Inc. (Nasdaq: ... announced a co-marketing agreement which will leverage Covaris, ... microfluidics technologies to develop automated workflows for next ... suite of solutions for library construction, sample analysis, ...
Cached Medicine Technology:St. Joseph Health System Selects Allscripts Care Management and Homecare Solutions 2St. Joseph Health System Selects Allscripts Care Management and Homecare Solutions 3St. Joseph Health System Selects Allscripts Care Management and Homecare Solutions 4St. Joseph Health System Selects Allscripts Care Management and Homecare Solutions 5Caliper and Covaris Establish Co-Marketing Agreement to Simplify Next Generation Sequencing 2Caliper and Covaris Establish Co-Marketing Agreement to Simplify Next Generation Sequencing 3
(Date:7/7/2015)... ... July 07, 2015 , ... Leading healthcare ... Jay Warden as Senior Vice President, heading the firm’s Healthcare Advisory Services division. ... best solutions to healthcare providers’ needs in ways that strengthen their position in ...
(Date:7/7/2015)... ... July 07, 2015 , ... More than ... Dial and Howdy’s, raised more than $524,286 during the Muscular Dystrophy Association's ... $100,000, to help support children fighting muscular dystrophy and related life-threatening diseases ...
(Date:7/7/2015)... ... , ... Difass USA, a modern supplement brand committed to excellence, understands that ... is knowing that there is hopefully a vacation to look forward to this summer. ... for a vacation can be quite stressful, and it’s difficult sometimes to fully disconnect ...
(Date:7/7/2015)... ... July 07, 2015 , ... ... is debuting their brand new website. The website’s goal is to provide patients ... selection of patient tools, including requesting appointments online. , Part of the center’s ...
(Date:7/7/2015)... Seattle, Washington (PRWEB) , ... ... ... and San Francisco-based Hope Consulting announced today that the two firms have ... organizations in the social, health and biopharma sectors. The merger combines SwitchPoint’s ...
Breaking Medicine News(10 mins):Health News:Hammes Company Hires Jay Warden to Lead Healthcare Advisory Services 2Health News:Hammes Company Hires Jay Warden to Lead Healthcare Advisory Services 3Health News:Western Refining Raises $524,286 to Help Send Kids with Neuromuscular Disease to MDA Summer Camp 2Health News:Western Refining Raises $524,286 to Help Send Kids with Neuromuscular Disease to MDA Summer Camp 3Health News:Difass USA Offers Eight Tips to Help Relax and Enjoy Summer Vacation 2Health News:Difass USA Offers Eight Tips to Help Relax and Enjoy Summer Vacation 3Health News:Northeast Nebraska Imaging Launches New Patient Friendly Website 2Health News:SwitchPoint and Hope Consulting Have Merged to Form Camber Collective 2
... these factors influence how likely they are to ... Racial and ethnic variations in how women perceive their ... get screened for cancer, particularly colon cancer, says a ... researchers interviewed 1,160 women, ages 50 to 80, about ...
... In Time For Summer, CINCINNATI, April 15 ... Americans beautify their insides this summer,with the addition of ... lineup. Pink Lemonade joins Berry Burst and Orange flavors ... 100 percent,fiber from psyllium husk making it a delicious ...
... 15 Gentiva Health,Services, Inc. (Nasdaq: GTIV ), ... services, today announced that it has,scheduled a conference call ... 10:00,a.m. ET to discuss operating results for the first ... financial news release the morning of May,1 before pre-market ...
... OF APPROXIMATELY $3.10-$3.20 PER ... DILUTED SHARE, NEW ... pharmaceutical company, today announced that,fully diluted earnings per share (EPS) for the ... share include a,charge of $110,138,000, or $0.35 per share net of tax, ...
... cancer drug Sutent may slow liver cancer progression, scientists ... A new drug duo might help prevent colorectal cancer, ... the progression of liver cancer. , So conclude two ... Research annual meeting in San Diego. , In the ...
... April 15 Wellcorps International, one of,the nations ... a major paper on the history and evolution ... can be found in its entirety at, http://www.wellcorps.com ... Tony Rich and noted,clinical medical anthropologist Meg Jordan, ...
Cached Medicine News:Health News:Women's Awareness of Cancer Risk Linked to Race, Ethnicity 2Health News:Quench Your Summer Thirst...With Fiber 2Health News:Quench Your Summer Thirst...With Fiber 3Health News:Gentiva(R) Health Services Schedules First Quarter Earnings Call and Web Cast for Thursday, May 1, 2008 2Health News:Gentiva(R) Health Services Schedules First Quarter Earnings Call and Web Cast for Thursday, May 1, 2008 3Health News:Forest Laboratories, Inc. Reports Fiscal Year 2008 Fourth Quarter Reported EPS of $0.55 Including $0.35 Per Share Charge for Licensing Payment 2Health News:Forest Laboratories, Inc. Reports Fiscal Year 2008 Fourth Quarter Reported EPS of $0.55 Including $0.35 Per Share Charge for Licensing Payment 3Health News:Forest Laboratories, Inc. Reports Fiscal Year 2008 Fourth Quarter Reported EPS of $0.55 Including $0.35 Per Share Charge for Licensing Payment 4Health News:Forest Laboratories, Inc. Reports Fiscal Year 2008 Fourth Quarter Reported EPS of $0.55 Including $0.35 Per Share Charge for Licensing Payment 5Health News:Forest Laboratories, Inc. Reports Fiscal Year 2008 Fourth Quarter Reported EPS of $0.55 Including $0.35 Per Share Charge for Licensing Payment 6Health News:Forest Laboratories, Inc. Reports Fiscal Year 2008 Fourth Quarter Reported EPS of $0.55 Including $0.35 Per Share Charge for Licensing Payment 7Health News:Forest Laboratories, Inc. Reports Fiscal Year 2008 Fourth Quarter Reported EPS of $0.55 Including $0.35 Per Share Charge for Licensing Payment 8Health News:Forest Laboratories, Inc. Reports Fiscal Year 2008 Fourth Quarter Reported EPS of $0.55 Including $0.35 Per Share Charge for Licensing Payment 9Health News:New Drug Duo Helps Fight Colon Cancer 2Health News:New Drug Duo Helps Fight Colon Cancer 3Health News:New Drug Duo Helps Fight Colon Cancer 4Health News:Wellcorps International Releases Major Paper on History and Evolution of Amphetamine and Anti-Depressant Use in America 2
... Practice management software for ... a true multi-tasking, multi-office practice ... in database technology- Winx Pro ... will assist you in effectively ...
The XT-1800i is a compact, high performance, automated hematology analyzer that provides accurate and precise CBC result including a fully automated WBC 5-part differential, and comprehensive test re...
The SE-9000 automated hematology analyzer provides accurate and precise CBC result including a fully automated WBC 5-part differential, and comprehensive test results for enhanced screening ability....
... offers three-dimensional VCS technology, ... and efficiency in white ... analysis. With its reputation ... HmX is an affordable ...
Medicine Products: